WallStreetZenWallStreetZen

NASDAQ: ARGX
Argenx Se Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Argenx Se earnings were $1.5B for the trailing 12 months ending Dec 31, 2025, with 71% growth year over year. The latest ARGX earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ARGX reported annual earnings of $1.5B, with 75.2% growth. The next ARGX earnings date is May 7, 2026.

ARGX past earnings growth

How has ARGX's earnings growth performed historically?

Company
71.03%
Industry
81.75%
Market
87.13%
ARGX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ARGX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ARGX's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ARGX earnings history

Current Revenue
$0.0
Current Earnings
$1.5B
Current Profit Margin
0%

ARGX Return on Equity

Current Company
20.2%
Current Industry
-11%
Current Market
29.4%
ARGX's Return on Equity (20.2%)... subscribe to Premium to read more.
High Return on Equity Performance

ARGX Return on Assets

Current Company
17.4%
Current Industry
-7.5%
ARGX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ARGX announces earnings.

ARGX Return on Capital Employed

Current Company
17.42%
Current Industry
-1.8%
ARGX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ARGX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ARGX$1.51B$1.49B+71.03%$24.23
ALNY$631.44M$313.75MN/A$2.39
ONC$616.77M$286.93MN/A$0.20
INSM-$1.16B-$1.28BN/A-$6.42
RPRX$1.08B$770.95M+6.28%$1.79
View Top Biotech Stocks

ARGX earnings dates

Next earnings date
May 7, 2026

Argenx Se Earnings Reports & History FAQ

What were Argenx Se's earnings last quarter?

On ARGX's earnings call on Invalid Date, Argenx Se (NASDAQ: ARGX) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total ARGX earnings for the quarter were N/A. In the same quarter last year, Argenx Se's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Argenx Se stock.

When does Argenx Se report earnings?

The next ARGX earnings date is Invalid Date. Add ARGX to your watchlist to be reminded of Argenx Se's next earnings date.

Is Argenx Se profitable or losing money?

As of the last Argenx Se earnings report, Argenx Se is currently profitable. Argenx Se's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $1.52 billion, a 75.17% increase year over year.

What was ARGX's earnings growth in the past year?

As of Argenx Se's earnings date in Invalid Date, Argenx Se's earnings has grown 71.03% year over year. This is 10.71 percentage points lower than the US Biotechnology industry earnings growth rate of 81.75%. ARGX earnings in the past year totalled $1.49 billion.

What are Argenx Se's earnings expectations?

The current EPS estimate for Argenx Se's earnings report in Invalid Date is $7.16.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.